Impaired antibody response to COVID-19 vaccination in blood cancer and arthritis patients after treatment with widely used drug

Certain blood cancer and arthritis patients have a significantly reduced antibody response to double COVID-19 vaccination in the first six months of being treated with a widely used drug, reveals a new study. The research, published in journal Clinical & Experimental Immunology, was carried out by experts across the Universities of Birmingham and Wolverhampton, The Royal … Continue reading “Impaired antibody response to COVID-19 vaccination in blood cancer and arthritis patients after treatment with widely used drug”

Prior SARS-CoV-2 infection increases strength and quality of immune response in double vaccinated care home staff and residents

Prior SARS-CoV-2 infection increases strength and quality of immune response in double vaccinated care home staff and residents, reveals study Elderly care home residents who have previously contracted and survived COVID-19 develop much stronger and higher antibody and cellular immune responses to two doses of vaccination than those without prior natural infection, finds new research … Continue reading “Prior SARS-CoV-2 infection increases strength and quality of immune response in double vaccinated care home staff and residents”

Birmingham in COVID-19 vaccine booster clinical trial

Six COVID-19 vaccines are safe and boost immunity for people who have had two doses of Pfizer/BioNTech or Oxford/AstraZeneca, show results from a UK-wide trial carried out in collaboration with BHP founder member the University of Birmingham. The latest results from the world-first study COV-BOOST are published in The Lancet and have been key in shaping the UK … Continue reading “Birmingham in COVID-19 vaccine booster clinical trial”

Living with Long Covid: when your normal becomes everyone’s ‘new normal’

Written exclusively for BHP by Rebecca Riley, Administrative Director of City-REDI, this piece reflects on the journey of someone who, already living with a complex and debilitating rare disease, is now experiencing Long Covid. As researchers’ understanding of SARS-CoV-2 continues to evolve, can we learn lessons from other prolonged disorders as we seek to understand … Continue reading “Living with Long Covid: when your normal becomes everyone’s ‘new normal’”

Birmingham to commercialise anti-viral nasal spray against COVID-19

Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and BHP founder-member the University of Birmingham have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against COVID-19. COVID-19 is both contracted and transmitted by inhalation of droplets or aerosols containing the SARS-CoV-2 virus, and … Continue reading “Birmingham to commercialise anti-viral nasal spray against COVID-19”